Biopharma Firms See 5.7 Percent Market Cap Drop in Q2 2025: Globaldata
Twenty biopharmaceutical companies have reported a 5.7 percent quarter-on-quarter (QoQ) downturn in their combined market capitalisation from USD 3.9 trillion on 31 March, 2025 to USD 3.7 trillion on 30 June, 2025.
Market | 01/09/2025 | By Dineshwori | 289
Stada Eyes Autumn IPO as Sale Talks Stall and Market Conditions Improve
Stada and its owners are also considering alternative ownership options, including a potential sale. The company previously held talks with private equity firm CapVest, which would have valued Stada at around 10 billion euro including debt. Those discussions have since stalled, prompting a stronger push toward the IPO route.
Market | 29/08/2025 | By Darshana | 175
While North America is projected to remain the largest market for pharmaceutical stability and storage services, the Asia-Pacific (APAC) region is expected to record the fastest CAGR during the forecast period.
Market | 29/08/2025 | By Dineshwori | 208
Santhera Partners with Ikris Pharma Network for Distribution of AGAMREE in India
Swiss specialty pharma company Santhera Pharmaceuticals has entered into an exclusive agreement with Ikris Pharma Network to distribute AGAMREE (vamorolone) in India for the treatment of Duchenne muscular dystrophy (DMD) in patients aged four years and above.
Market | 29/08/2025 | By Dineshwori | 603
Esaote North America and Epica International Partner to Expand MRI and CT Imaging Market Reach
Esaote North America has entered into a strategic partnership with Epica International to expand market presence and accelerate the adoption of high-performance MRI and CT solutions across the human and veterinary healthcare sectors.
Market | 28/08/2025 | By Dineshwori | 170
Osstem Implant Strengthens Global Footprint with India as Key Growth Market
Osstem Implant’s success in India – one of the fastest-growing dental implant markets – is driven by a dual focus on innovation and education.
Market | 28/08/2025 | By Dineshwori | 566
Laborate's Aqualab Eyes INR 250 Crore with Retail-First Model by FY 25-26
Since its inception in 2022, Laborate’s direct-to-retail division, Aqualab, has reported consistent year-on-year growth, moving from INR 76 crore in FY 2022–23 to INR 108 crore in FY 2023–24.
Market | 27/08/2025 | By Dineshwori | 456
US EoE Market Expected to Hit USD 1.19 Billion by 2030, Driven by Next-Gen Therapies
The US market for eosinophilic esophagitis (EoE) is projected to soar from USD 202 million in 2020 to USD 1.19 billion by 2030, reflecting a compound annual growth rate (CAGR) of 19.4 percent, according to GlobalData. This substantial growth is being driven by a transition away from off-label treatments toward FDA-approved, patient-friendly therapies.
Market | 25/08/2025 | By Darshana | 241
Novo Nordisk Implements Global Hiring Freeze Amid Wegovy Pressure
Novo Nordisk, the pharmaceutical major behind the blockbuster obesity drug Wegovy, has imposed a global hiring freeze, halting recruitment for all non-critical positions. The move reflects intensifying pressure from increasing competition and market volatility.
Market | 21/08/2025 | By Darshana | 240
India's Drugs and Pharma Exports Rise 14 Percent in July
India’s exports of drugs and pharmaceuticals rose sharply in July 2025, reaching USD 2,662.24 million, up from USD 2,334.14 million in the same month last year , according to the latest trade data released by the Department of Commerce.
Market | 20/08/2025 | By Dineshwori | 289
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy